{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:23:23Z","timestamp":1792499003910,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Addiction to sedative, hypnotic, and anxiolytic drugs (collectively referred to as benzodiazepines), medications commonly used to treat anxiety and sleeping problems, has been described as a hidden epidemic. Growing concerns about addiction and other negative outcomes associated with use of these narcotics have resulted in their regulation and recommendations for more restrictive prescription. However, there are few studies on experiences of long-term benzodiazepine use from the user perspective, and even fewer focusing on people with addiction, who may be the most affected by changing regulations. The aim of this study was to explore experiences of people with long-term use and addiction to benzodiazepines during a time of major changes in guidelines for the prescription of narcotic drugs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This qualitative study included nineteen individual interviews with adults (&gt;\u200918 years) diagnosed with addiction to benzodiazepines who were undergoing treatment at an urban outpatient clinic in Sweden. The in-depth interviews were pseudonymized, transcribed verbatim, and analyzed using reflexive thematic analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Two themes highlight the effect of changing prescription guidelines on long-term benzodiazepine users. The first theme, <jats:italic>benzodiazepines were not always seen as problematic<\/jats:italic>,<jats:italic> but neither were the risks discussed<\/jats:italic>, underscores the absence of psychiatric assessments and conversations about risks at the time of first prescription and highlights the need for clearer communication. The second theme, <jats:italic>entangled in continued benzodiazepine use and increasing restrictions on prescribing<\/jats:italic>, illustrates how addiction developed over time and describes how limited contact with prescribers facilitated long-term use, which often persisted until the participants were faced with deprescription.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study describes the experiences of individuals with long-term use and addiction to benzodiazepines during a time of shifting attitudes towards prescribing. The results highlight areas for improvement in care for this vulnerable group of patients, including the need for proactive and regular communication about risks of addiction and additional support during deprescription.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12889-025-23920-9","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T11:16:29Z","timestamp":1754392589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Experiences of long-term benzodiazepine use and addiction amid changes in guidelines for the prescription of narcotic drugs: a qualitative study"],"prefix":"10.1186","volume":"25","author":[{"given":"Cecilia","family":"Kr\u00fcger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde Hedlund","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Burmester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Franck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Westman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"issue":"8","key":"23920_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMp1715050","volume":"378","author":"A Lembke","year":"2018","unstructured":"Lembke A, Papac J, Humphreys K. Our other prescription drug problem. N Engl J Med. 2018;378(8):693\u20135.","journal-title":"N Engl J Med"},{"issue":"5","key":"23920_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/00912174231166252","volume":"58","author":"DL Louie","year":"2023","unstructured":"Louie DL, Jegede OO, Hermes GL. Chronic use of benzodiazepines: the problem that persists. Int J Psychiatry Med. 2023;58(5):426\u201332.","journal-title":"Int J Psychiatry Med"},{"key":"23920_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","volume":"200","author":"VR Votaw","year":"2019","unstructured":"Votaw VR, Geyer R, Rieselbach MM, McHugh RK. The epidemiology of benzodiazepine misuse: A systematic review. Drug Alcohol Depend. 2019;200:95\u2013114.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"23920_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","volume":"18","author":"H Ashton","year":"2005","unstructured":"Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry. 2005;18(3):249\u201355.","journal-title":"Curr Opin Psychiatry"},{"key":"23920_CR5","doi-asserted-by":"crossref","unstructured":"Lader M. Benzodiazepines revisited\u2013will we ever learn? Addiction. 2011, 106(12):2086\u2013109.","DOI":"10.1111\/j.1360-0443.2011.03563.x"},{"issue":"8","key":"23920_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","volume":"30","author":"TA Kurko","year":"2015","unstructured":"Kurko TA, Saastamoinen LK, T\u00e4hk\u00e4p\u00e4\u00e4 S, Tuulio-Henriksson A, Taiminen T, Tiihonen J. Long-term use of benzodiazepines: definitions, prevalence and usage patterns - a systematic review of register-based studies. Eur Psychiatry. 2015;30(8):1037\u201347.","journal-title":"Eur Psychiatry"},{"issue":"11","key":"23920_CR7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0269881113503509","volume":"27","author":"DS Baldwin","year":"2013","unstructured":"Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S. Leonard bet al. Benzodiazepines: risks and benefits. A reconsideration. J Psychopharmacol. 2013;27(11):967\u201371.","journal-title":"J Psychopharmacol"},{"key":"23920_CR8","unstructured":"The Swedish Council for Information on Alcohol and Other Drugs. Anv\u00e4ndning och beroendeproblem av alkohol, narkotika och tobak. En studie med fokus p\u00e5 \u00e5r 2021 i Sverige [Use and problems related to additction to alcohol, drugs and tobacco. A study with focus on year 2021 in Sweden]. 2022."},{"issue":"6","key":"23920_CR9","first-page":"e15816","volume":"13","author":"A Sarangi","year":"2021","unstructured":"Sarangi A, McMahon T, Gude J. Benzodiazepine misuse: an epidemic within a pandemic. Cureus. 2021;13(6):e15816.","journal-title":"Cureus"},{"key":"23920_CR10","doi-asserted-by":"publisher","first-page":"1129447","DOI":"10.3389\/fpsyt.2023.1129447","volume":"14","author":"RK McHugh","year":"2023","unstructured":"McHugh RK, Votaw VR, Trapani EW, McCarthy MD. Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National survey on drug use and health. Front Psychiatry. 2023;14:1129447.","journal-title":"Front Psychiatry"},{"issue":"8","key":"23920_CR11","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00228-023-03515-2","volume":"79","author":"K Isomura","year":"2023","unstructured":"Isomura K, Wang X, Chang Z, Hellner C, Hasselstrom J, Ekheden I. Factors associated with long-term benzodiazepine and Z-drug use across the lifespan and 5-year Temporal trajectories among incident users: a Swedish nationwide register-based study. Eur J Clin Pharmacol. 2023;79(8):1091\u2013105.","journal-title":"Eur J Clin Pharmacol"},{"key":"23920_CR12","unstructured":"L\u00e4kemedelsverkets f\u00f6reskrifter om f\u00f6rteckningar \u00f6ver narkotika. [The Swedish Medical Product Agency\u2019s regulation on narcotics] (LVFS 2011:10). Stockholm: Swedish Medical Products Agency. 2011."},{"key":"23920_CR13","doi-asserted-by":"publisher","first-page":"102507","DOI":"10.1016\/j.eclinm.2024.102507","volume":"70","author":"J Brandt","year":"2024","unstructured":"Brandt J, Bressi J, Le ML, Neal D, Cadogan C, Witt-Doerring J. Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review. EClinicalMedicine. 2024;70:102507.","journal-title":"EClinicalMedicine"},{"issue":"4","key":"23920_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","volume":"17","author":"J Brandt","year":"2017","unstructured":"Brandt J, Leong C. Benzodiazepines and Z-Drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs R D. 2017;17(4):493\u2013507.","journal-title":"Drugs R D"},{"key":"23920_CR15","unstructured":"National Board of Health and Welfare. Nationella riktlinjer f\u00f6r v\u00e5rd vid depression och \u00e5ngestsyndrom 2010. St\u00f6d f\u00f6r styrning och ledning [National guidelines for care in depression and anxiety disorders 2010. Support for control and management]. Nationella riktlinjer inom missbruk och beroende, Report number 2010-3-4. 2010."},{"key":"23920_CR16","unstructured":"National Board of Health and Welfare. Nationella riktlinjer f\u00f6r v\u00e5rd vid depression och \u00e5ngestsyndrom. St\u00f6d f\u00f6r styrning och ledning [National guidelines for care in depression and anxiety disorders. Support for control and management]. Nationella riktlinjer f\u00f6r v\u00e5rd vid depression och \u00e5ngestsyndrom, Report number 2021-4-7339. 2021."},{"key":"23920_CR17","unstructured":"The Swedish Agency for Health Technology Assessment and Assessment of Social Services. Behandling av s\u00f6mnbesv\u00e4r hos vuxna. En systematisk litteratur\u00f6versikt. [Treatment of insomnia in adults. A systematic literature review]. Report number 199. 2010."},{"key":"23920_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1471-2296-14-191","volume":"14","author":"C Sirdifield","year":"2013","unstructured":"Sirdifield C, Anthierens S, Creupelandt H, Chipchase SY, Christiaens T, Siriwardena AN. General practitioners\u2019 experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Fam Pract. 2013;14:191.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"23920_CR19","doi-asserted-by":"publisher","first-page":"e1998","DOI":"10.1002\/mpr.1998","volume":"33","author":"E Dahl\u00e9n","year":"2024","unstructured":"Dahl\u00e9n E, Bardage C, Tuvendal P, Ljung R. New users of anxiolytics and sedatives in Sweden-Drug type, doses, prescribers\u2019 characteristics, and psychiatric comorbidity in more than 750,000 patients. Int J Methods Psychiatr Res. 2024;33(1):e1998.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"1","key":"23920_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40271-016-0182-z","volume":"10","author":"C Sirdifield","year":"2017","unstructured":"Sirdifield C, Chipchase SY, Owen S, Siriwardena AN. A systematic review and Meta-Synthesis of patients\u2019 experiences and perceptions of seeking and using benzodiazepines and Z-Drugs: towards safer prescribing. Patient. 2017;10(1):1\u201315.","journal-title":"Patient"},{"issue":"11","key":"23920_CR21","doi-asserted-by":"publisher","first-page":"e0142057","DOI":"10.1371\/journal.pone.0142057","volume":"10","author":"M Liebrenz","year":"2015","unstructured":"Liebrenz M, Schneider M, Buadze A, Gehring MT, Dube A, Caflisch C. High-Dose benzodiazepine dependence: A qualitative study of patients\u2019 perceptions on initiation, reasons for use, and obtainment. PLoS ONE. 2015;10(11):e0142057.","journal-title":"PLoS ONE"},{"key":"23920_CR22","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders fifth ed","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders fifth ed. Washington DC: American Psychiatric Association (APA); 2013."},{"key":"23920_CR23","doi-asserted-by":"publisher","first-page":"209508","DOI":"10.1016\/j.josat.2024.209508","volume":"167","author":"S Burmester","year":"2024","unstructured":"Burmester S, Kruger C, Franck J, Lindberg MH, Westman J. At the tipping point: patient experiences of addiction to benzodiazepines and motivation to seek treatment. J Subst Use Addict Treat. 2024;167:209508.","journal-title":"J Subst Use Addict Treat"},{"issue":"13","key":"23920_CR24","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1049732315617444","volume":"26","author":"K Malterud","year":"2016","unstructured":"Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016;26(13):1753\u201360.","journal-title":"Qual Health Res"},{"issue":"9","key":"23920_CR25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","volume":"89","author":"BC O\u2019Brien","year":"2014","unstructured":"O\u2019Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245\u201351.","journal-title":"Acad Med"},{"key":"23920_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-69909-7_3470-2","volume-title":"Thematic analysis: A practical guide","author":"V Braun","year":"2022","unstructured":"Braun V, Clarke V. Thematic analysis: A practical guide. Thousand Oaks, CA: SAGE Publications Ltd; 2022."},{"issue":"3","key":"23920_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/14780887.2020.1769238","volume":"18","author":"V Braun","year":"2020","unstructured":"Braun V, Clarke V. One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qualitative Res Psychol. 2020;18(3):328\u201352.","journal-title":"Qualitative Res Psychol"},{"key":"23920_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/B978-0-12-398336-7.00006-1","volume-title":"Principles of addiction: comprehensive addictive behaviors and disorders","author":"MC Skewes","year":"2013","unstructured":"Skewes MC, Gonzalez VM. The biopsychosocial model of addiction. In: Miller, editor. Principles of addiction: comprehensive addictive behaviors and disorders. 1 ed. San Diego: Elsevier Science and Technology; 2013. pp. 61\u201370.","edition":"1"},{"issue":"3","key":"23920_CR29","first-page":"217","volume":"34","author":"M Andersson","year":"2017","unstructured":"Andersson M, Kjellgren A. The slippery slope of flubromazolam: experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum. Nordisk Alkohol Nark. 2017;34(3):217\u201329.","journal-title":"Nordisk Alkohol Nark"},{"issue":"5","key":"23920_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.hrtlng.2013.05.003","volume":"42","author":"LK Andrews","year":"2013","unstructured":"Andrews LK, Coviello J, Hurley E, Rose L, Redeker NS. I\u2019d eat a bucket of nails if you told me it would help me sleep: perceptions of insomnia and its treatment in patients with stable heart failure. Heart Lung. 2013;42(5):339\u201345.","journal-title":"Heart Lung"},{"key":"23920_CR31","doi-asserted-by":"crossref","unstructured":"Reid Finlayson AJ, Macoubrie J, Huff C, Foster DE, Martin PR. Experiences with benzodiazepine use, tapering, and discontinuation: an internet survey. Ther Adv Psychopharmacol. 2022, 12:20451253221082386.","DOI":"10.1177\/20451253221082386"},{"issue":"8","key":"23920_CR32","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s11606-007-0205-5","volume":"22","author":"JM Cook","year":"2007","unstructured":"Cook JM, Biyanova T, Masci C, Coyne JC. Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study. J Gen Intern Med. 2007;22(8):1094\u2013100.","journal-title":"J Gen Intern Med"},{"key":"23920_CR33","doi-asserted-by":"crossref","unstructured":"Mokhar A, Kuhn S, Topp J, Dirmaier J, H\u00e4rter M, Verthein U. Long-term use of benzodiazepines and Z drugs: a qualitative study of patients\u2019 and healthcare professionals\u2019 perceptions and possible levers for change. BJGP Open. 2019, 3(1):bjgpopen18X101626.","DOI":"10.3399\/bjgpopen18X101626"},{"issue":"5","key":"23920_CR34","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1002\/hsr2.116","volume":"2","author":"FT Sake","year":"2019","unstructured":"Sake FT, Wong K, Bartlett DJ, Saini B. Benzodiazepine usage and patient preference for alternative therapies: A descriptive study. Health Sci Rep. 2019;2(5):e116.","journal-title":"Health Sci Rep"},{"issue":"1\u20132","key":"23920_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC van Boekel","year":"2013","unstructured":"van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1\u20132):23\u201335.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"23920_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jama.2020.22106","volume":"325","author":"ME Hirschtritt","year":"2021","unstructured":"Hirschtritt ME, Olfson M, Kroenke K. Balancing the risks and benefits of benzodiazepines. JAMA. 2021;325(4):347\u20138.","journal-title":"JAMA"},{"issue":"6","key":"23920_CR37","first-page":"470","volume":"21","author":"A Chandler","year":"2014","unstructured":"Chandler A, Whittaker A, Williams N, McGorm K, Cunningham-Burley S, Mathews G. Mother\u2019s little helper? Contrasting accounts of benzodiazepine and methadone use among drug-dependent parents in the UK. Drugs (Abingdon Engl). 2014;21(6):470\u20135.","journal-title":"Drugs (Abingdon Engl)"},{"key":"23920_CR38","unstructured":"National Board of Health and Welfare. Nationella riktlinjer f\u00f6r v\u00e5rd och st\u00f6d vid missbruk och beroende. St\u00f6d f\u00f6r styrning och ledning [National guidelines for care and support in cases of addiction and dependence. Support for control and management]. Report number 2019-1-16. 2019."},{"issue":"708","key":"23920_CR39","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.3399\/BJGP.2020.1062","volume":"71","author":"E Oldenhof","year":"2021","unstructured":"Oldenhof E, Mason T, Anderson-Wurf J, Staiger PK. Role of the prescriber in supporting patients to discontinue benzodiazepines: a qualitative study. Br J Gen Pract. 2021;71(708):e517\u201327.","journal-title":"Br J Gen Pract"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23920-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23920-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23920-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:47:57Z","timestamp":1757357277000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23920-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23920"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23920-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Swedish National Ethical Review Authority (Dnr. 2019\u201305302) and was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent prior to study start.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2652"}}